<- Go Home
Enzo Biochem, Inc.
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$52.8M
Volume
100.1K
Cash and Equivalents
$47.7M
EBITDA
-$9.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$13.5M
Profit Margin
44.39%
52 Week High
$1.50
52 Week Low
$0.93
Dividend
39.60%
Price / Book Value
N/A
Price / Earnings
-6.92
Price / Tangible Book Value
N/A
Enterprise Value
$8.3M
Enterprise Value / EBITDA
-0.96
Operating Income
-$10.5M
Return on Equity
-11.83%
Return on Assets
-7.24
Cash and Short Term Investments
$47.7M
Debt
$3.3M
Equity
$47.7M
Revenue
$30.3M
Unlevered FCF
-$227.4K
Sector
Health Care Providers and Services
Category
N/A